Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-21

FDA Approved: ATAZANAVIR SULFATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for atazanavir sulfate from Aurobindo Pharma Limited, effectively approving this generic HIV protease inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atazanavir sulfate (atazanavir)

Snippet

SUPPL AP for ATAZANAVIR SULFATE (ATAZANAVIR)